Navigation Links
JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM)
Date:2/27/2008

CHARLESTON, S.C., Feb. 27 /PRNewswire/ -- JSJ Pharmaceuticals is pleased to announce the introduction of its new aesthetic division, Vitivia(TM). Vitivia(TM) will focus on medically based aesthetics and utilize the clinical roots of JSJ Pharmaceuticals in the development of science-based, result-oriented products.

Vitivia(TM)'s first product introduction will be its Pro:Vitamin line. Topical vitamins have long been recognized as important tools in the anti-aging process. The benefits of most topical vitamins, however, have been limited by the inability to stabilize vitamins when exposed to air and light. For products that have attempted to address this stability issue, long lists of preservative agents have been the answer. Vitivia(TM)'s Pro:Vitamin has found an innovative solution to these challenges.

In light of the fact that today's consumers desire natural ingredients, free of chemical preservatives, fragrances, coloring, or other allergens, Vitivia(TM)'s Pro:Vitamin line combines pure concentrations of natural ingredients with the best of modern science. This formulation is then placed in individual biodegradable unit dose packaging insuring each application of Pro:Vitamin has never been exposed to light or air. As a result, the concentration of the first application is as pure and stable as the last.

"With the continued growth of medically based aesthetics, Vitivia(TM) will be an important growth factor for the future of JSJ Pharmaceuticals," stated JSJ's Chief Operating Officer, Jonathan Alba. "The introduction of the clinically proven Pro:Vitamin line will be a key part of the long-term foundation of the Vitivia(TM) division of JSJ," stated Alba.

Vitivia(TM)'s Pro:Vitamin line is available through physician offices nationally. For more information regarding the purchase or distribution of Vitivia(TM) products visit http://www.Vitivia.com or call 1-888-975-4848.

About JSJ:

JSJ Pharmaceuticals, based in Charleston, SC, is a growing specialty pharmaceutical company focused on the development and commercialization of prescriptive products to meet the diverse needs of patients suffering from a wide range of dermatological conditions. More information can be found about JSJ Pharmaceuticals at http://www.jsjpharm.com.

Media Contact:

Jon Knowles

843.965.8333 ext. 104

jknowles@jsjpharm.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE JSJ Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
2. NPS Pharmaceuticals Announces Senior Management Changes
3. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
4. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
5. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
7. Nycomed US Inc. Acquires Bradley Pharmaceuticals, Inc.
8. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
9. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
10. Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split
11. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Rolf K. Hoffmann, former senior vice ... University of North Carolina Kenan-Flagler Business School effective June 27. , ... with a focus on the school’s international efforts, leading classes and participating in ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS ... the launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, ... proud to add Target to its list of well-respected retailers. This list includes ...
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/16/2016)...   EyeLock LLC , a market leader of ... an IoT Center of Excellence in Austin, ... of embedded iris biometric applications. EyeLock,s iris ... security with unmatched biometric accuracy, making it the most ... EyeLock,s platform uses video technology to deliver a fast ...
Breaking Biology News(10 mins):